Recent News

Characterizing Bacteriophage-Derived Enzymes That Degrade Staphylococcus Biofilms October 20, 2017Employing the xCELLigence® technology from ACEA Biosciences, a team of Spanish scientists have developed a real-time assay for screening anti-biofilm treatments and quantifying their efficacy Biofilms are surface-attached communities of bacterial or fungal cells that are enmeshed in an extensive extracellular matrix which makes them more resistant to both antibiotics and the immune system. With biofilms estimated to be responsible ... Read More
Pluriomics BV Announced Cooperation with ACEA Biosciences to Advance Cardiovascular Drug Discovery and the Expansion of its Services Portfolio August 25, 2017Leiden, The Netherlands, August 21, 2017. Pluriomics and ACEA Biosciences (ACEA) today announced a cooperation to advance together cardiac drug discovery and expand Pluriomics service portfolio. This cooperation will give Pluriomics access to ACEA xCELLigence® Real-Time Cell Analysis (RTCA) CardioECR instrument which enables them to simultaneously assess cardiomyocyte contractility, viability, and electrophysiology. Pluriomics, a leading expert in human cardiovascular stem ... Read More
ACEA Biosciences Announces Collaboration with Memorial Sloan Kettering Cancer Center on Personalized CAR T Cell Therapy August 9, 2017MSK and ACEA will evaluate whether patient-specific ex-vivo cancer immunotherapy assays are predictive of in vivo efficacy. ACEA Biosciences and Memorial Sloan Kettering Cancer Center (MSK) have entered into a collaboration to evaluate a personalized ex vivo potency assay using cancer patients’ malignant pleural effusions and ACEA’s xCELLigence Real-Time Cell Analysis (RTCA) instrument to monitor destruction of the cancer cells ... Read More
ACEA Biosciences Introduces a Multi-Option Configuration NovoCyte® Flow Cytometer May 3, 2017ACEA Biosciences continues to innovate and improve its already flexible and easy to use NovoCyte Flow Cytometry system by developing new capabilities to expand users’ breadth of options. The NovoCyte system with its updated software and firmware provides broader versatility and flexibility with its multi-option optical configuration capabilities. This update also brings the release of the new ACEA NovoCyte 3005 ... Read More
Cancer and Immunotherapy Symposium Hosted by ACEA Biosciences Gathers Clinicians and Scientists From Around the World April 7, 2017Researchers from academia, industry, and federal agencies convened in Washington, D.C. this week to discuss recent progress in diverse areas of basic and applied cancer research. As a forum to promote scientific exchange and collaboration among scientists working at the forefront of cancer related disciplines, ACEA Biosciences hosted its annual Cancer and Immunotherapy symposium March 31-April 1 at the Renaissance ... Read More
View all News

  Upcoming Events

SITC 2017 | November 8-12 | National Harbor, MD.Join ACEA Booth #734 at the Society for Immunotherapy of Cancer (SITC) for our 32nd Annual Meeting & Pre-Conference Programs Nov. 8-12, 2017 at the Gaylord National Hotel & Convention Center in National Harbor, Md. This conference is known as the premier destination for scientific exchange, education and networking in the cancer immunotherapy field, this is the conference you don’t ... Read More
CYTO ASIA 2017 | October 25-27 | Singapore.Come visit ACEA at CYTO Asia from October 25-27, 2017. CYTO Asia will consist of a three-day scientific conference covering both clinical and research based cytometry, featuring plenary, parallel and poster sessions.Read More
Cancer Sciences Annual Conference 2017 | October 20 | United Kingdom.Come visit our table at the 2017 Cancer Sciences Annual Conference on Friday 20th October 2017 at Chilworth Manor Hotel.  It will be a chance to showcase the breadth and quality of research being carried out by Cancer Sciences Unit!Read More
View all Events

  ACEA Newsletter

Sign up for the ACEA Newsletter.

View ACEA Newsletters